Shaida Khan, D.O.

Medical Director of Neurology, Parkland Hospital

  • Neurology
  • Autoimmune Neurology
  • Neuromuscular Disorders
Education & Training
  • Fellowship - UT Southwestern Medical Center (2016-2018), Neuromuscular Disease
  • Residency - UT Southwestern Medical Center (2012-2016), Neurology
  • Medical School - UNT Health Science Center at Fort Worth (2008-2012)
Professional Associations & Affiliations
  • Texas Neurological Society (2018)
  • American Academy of Neurology (2012)
  • Alpha Omega Alpha Honor Society (2013)
Honors & Awards
  • Fred Baskin Young Investigator Award 2017
  • UTSW Wellstone MDCRC Training Grant 2016-2018, NIH grant
  • 2017 AAN Fellow Scholarship to the Annual Meeting 2017
  • Chief Resident 2015-2016
  • Roger Rosenberg Fellow of the Year Award 2016-2017
Books & Publications
  • Publications
    • Predictors of Death in Adults With Duchenne Muscular Dystrophy-Associated Cardiomyopathy.
      Cheeran D, Khan S, Khera R, Bhatt A, Garg S, Grodin JL, Morlend R, Araj FG, Amin AA, Thibodeau JT, Das S, Drazner MH, Mammen PPA Journal of the American Heart Association 2017 Oct 6 10
    • Cardiac Atrophy: a Novel Mechanism for Duchenne Muscular Dystrophy (DMD)-Associated Cardiomyopathy
      Shaida Khan, Daniel Cheeran, Sonia Garg, Justin Grodin, Robert Morlend, Faris Araj, Alpesh Amin, Jennifer Thibodeau, Mark Drazner and Pradeep Mammen Journal of the American College of Cardiology 2017 69 11
    • Bilateral Asymmetrical Asterixis as Limb-shaking Transient Ischemic Attack in Bilateral Carotid Stenosis.
      Khan S, Chang E, Saniuk G, Shang T Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2015 Jan 24 1 e29-30
    • Brody Myopathy Presenting as Recurrent Rhabdomyolysis
      Colin Bergstrom MD, Matthew Remz MD, Shaida Khan DO, Markey McNutt II MD PhD 2021
    • Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial.
      Howard JF, Nowak RJ, Wolfe GI, Freimer ML, Vu TH, Hinton JL, Benatar M, Duda PW, MacDougall JE, Farzaneh-Far R, Kaminski HJ, Barohn R, Dimachkie M, Pasnoor M, Farmakidis C, Liu T, Colgan S, Benatar MG, Bertorini T, Pillai R, Henegar R, Bromberg M, Gibson S, Janecki T, Freimer M, Elsheikh B, Matisak P, Genge A, Guidon A, David W, Habib AA, Mathew V, Mozaffar T, Hinton JL, Hewitt W, Barnett D, Sullivan P, Ho D, Howard JF, Traub RE, Chopra M, Kaminski HJ, Aly R, Bayat E, Abu-Rub M, Khan S, Lange D, Holzberg S, Khatri B, Lindman E, Olapo T, Sershon LM, Lisak RP, Bernitsas E, Jia K, Malik R, Lewis-Collins TD, Nicolle M, Nowak RJ, Sharma A, Roy B, Nye J, Pulley M, Berger A, Shabbir Y, Sachdev A, Patterson K, Siddiqi Z, Sivak M, Bratton J, Small G, Kohli A, Fetter M, Vu T, Lam L, Harvey B, Wolfe GI, Silvestri N, Patrick K, Zakalik K, Duda PW, MacDougall J, Farzaneh-Far R, Pontius A, Hoarty M, JAMA neurology 2020 Feb
    • Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.
      Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, Dominov JA, Kenna BJ, Nalls MA, Keagle P, Rivera AM, van Rheenen W, Murphy NA, van Vugt JJFA, Geiger JT, Van der Spek RA, Pliner HA, ShankaracharyaSmith BN, Marangi G, Topp SD, Abramzon Y, Gkazi AS, Eicher JD, Kenna A, Mora G, Calvo A, Mazzini L, Riva N, Mandrioli J, Caponnetto C, Battistini S, Volanti P, La Bella V, Conforti FL, Borghero G, Messina S, Simone IL, Trojsi F, Salvi F, Logullo FO, D'Alfonso S, Corrado L, Capasso M, Ferrucci L, Moreno CAM, Kamalakaran S, Goldstein DB, Gitler AD, Harris T, Myers RM, Phatnani H, Musunuri RL, Evani US, Abhyankar A, Zody MC, Kaye J, Finkbeiner S, Wyman SK, LeNail A, Lima L, Fraenkel E, Svendsen CN, Thompson LM, Van Eyk JE, Berry JD, Miller TM, Kolb SJ, Cudkowicz M, Baxi E, Benatar M, Taylor JP, Rampersaud E, Wu G, Wuu J, Lauria G, Verde F, Fogh I, Tiloca C, Comi GP, Sorarù G, Cereda C, Corcia P, Laaksovirta H, Myllykangas L, Jansson L, Valori M, Ealing J, Hamdalla H, Rollinson S, Pickering-Brown S, Orrell RW, Sidle KC, Malaspina A, Hardy J, Singleton AB, Johnson JO, Arepalli S, Sapp PC, McKenna-Yasek D, Polak M, Asress S, Al-Sarraj S, King A, Troakes C, Vance C, de Belleroche J, Baas F, Ten Asbroek ALMA, Muñoz-Blanco JL, Hernandez DG, Ding J, Gibbs JR, Scholz SW, Floeter MK, Campbell RH, Landi F, Bowser R, Pulst SM, Ravits JM, MacGowan DJL, Kirby J, Pioro EP, Pamphlett R, Broach J, Gerhard G, Dunckley TL, Brady CB, Kowall NW, Troncoso JC, Le Ber I, Mouzat K, Lumbroso S, Heiman-Patterson TD, Kamel F, Van Den Bosch L, Baloh RH, Strom TM, Meitinger T, Shatunov A, Van Eijk KR, de Carvalho M, Kooyman M, Middelkoop B, Moisse M, McLaughlin RL, Van Es MA, Weber M, Boylan KB, Van Blitterswijk M, Rademakers R, Morrison KE, Basak AN, Mora JS, Drory VE, Shaw PJ, Turner MR, Talbot K, Hardiman O, Williams KL, Fifita JA, Nicholson GA, Blair IP, Rouleau GA, Esteban-Pérez J, García-Redondo A, Al-Chalabi A, Rogaeva E, Zinman L, Ostrow LW, Maragakis NJ, Rothstein JD, Simmons Z, Coope Neuron 2018 Mar 97 6 1268-1283.e6
    • Autosomal Dominant ANO5-Related Disorder Associated With Myopathy and Gnathodiaphyseal Dysplasia
      Aziz Shaibani MD, Shaida Khan DO, Marwan Shinawi MD 2021
    • New patient access via telehealth in neuromuscular medicine during COVID-19.
      Khan S, Kramer A, McIver J, Cady L, Trivedi JR, Work (Reading, Mass.) 2021 Jun
Research
  • Muscular dystrophy

Clinical Focus

  • Autoimmune Neurology
  • Neuromuscular Disorders

See More

Showing 1 locations